NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
Fan Jiang1, Guei-Sheung Liu2, Gregory J Dusting2
1Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China.
Abstract:
Uncontrolled fibrosis in organs like heart, kidney, liver and lung is detrimental and may lead to end-stage organ failure. Currently there is no effective treatment for fibrotic disorders. Transforming growth factor (TGF)-β has a fundamental role in orchestrating the process of fibrogenesis; however, interventions directly targeting TGF-β would have undesired systemic side effects due to the multiple physiological functions of TGF-β. Further characterization of the downstream signaling pathway(s) involved in TGF-β-mediated fibrosis may lead to discovery of novel treatment strategies for fibrotic disorders. Accumulating evidence suggests that Nox4 NADPH oxidase may be an important downstream effector in mediating TGF-β-induced fibrosis, while NADPH oxidase-dependent redox signaling may in turn regulate TGF-β/Smad signaling in a feed-forward manner. It is proposed that pharmacological inhibition of the Nox4 function may represent a novel approach in treatment of fibrotic disorders.
Insights
Targeting Nox4 NADPH oxidase may offer a new treatment for organ fibrosis. This approach avoids systemic side effects associated with blocking transforming growth factor (TGF)-β directly, offering a novel therapeutic strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Uncontrolled organ fibrosis (heart, kidney, liver, lung) leads to organ failure with no effective treatments.
- Transforming growth factor (TGF)-β drives fibrogenesis, but direct inhibition causes systemic side effects.
- Novel therapeutic targets are needed for fibrotic disorders.
Purpose of the Study:
- To investigate downstream signaling pathways of TGF-β in fibrosis.
- To explore the role of Nox4 NADPH oxidase in TGF-β-mediated fibrosis.
- To evaluate pharmacological inhibition of Nox4 as a potential treatment strategy.
Main Methods:
- Analysis of TGF-β signaling pathways.
- Investigation of Nox4 NADPH oxidase activity in fibrotic processes.
- Assessment of redox signaling in TGF-β/Smad pathways.
Main Results:
- Nox4 NADPH oxidase acts as a downstream effector in TGF-β-induced fibrosis.
- NADPH oxidase-dependent redox signaling regulates TGF-β/Smad signaling in a feed-forward loop.
- Pharmacological inhibition of Nox4 is proposed as a novel therapeutic approach.
Conclusions:
- Nox4 is a key mediator in TGF-β-driven fibrosis.
- Targeting Nox4 offers a potential strategy for treating fibrotic disorders.
- Inhibiting Nox4 may circumvent the side effects of direct TGF-β blockade.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of Angiogenesis and Blood Supply
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
NF-kB-dependent Signaling Pathway
Chronic Inflammation: Introduction
